120 related articles for article (PubMed ID: 38918479)
1. An efficient plasmid-based system for the recovery of recombinant vesicular stomatitis virus encoding foreign glycoproteins.
Marqués MC; Andreu-Moreno I; Sanjuán R; Elena SF; Geller R
Sci Rep; 2024 Jun; 14(1):14644. PubMed ID: 38918479
[TBL] [Abstract][Full Text] [Related]
2. Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.
Slough MM; Chandran K; Jangra RK
mBio; 2019 Jan; 10(1):. PubMed ID: 30622188
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.
Locher S; Schweneker M; Hausmann J; Zimmer G
J Gen Virol; 2018 Jul; 99(7):866-879. PubMed ID: 29869979
[TBL] [Abstract][Full Text] [Related]
4. Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses.
Whitt MA; Geisbert TW; Mire CE
Methods Mol Biol; 2016; 1403():295-311. PubMed ID: 27076138
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.
Park JE; Shin HJ
Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418
[TBL] [Abstract][Full Text] [Related]
6. Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
Zhu Z; Han Y; Gong M; Sun B; Zhang R; Ding Q
J Virol; 2024 May; 98(5):e0195723. PubMed ID: 38557247
[TBL] [Abstract][Full Text] [Related]
7. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
Martinez I; Barrera JC; Rodriguez LL; Wertz GW
Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
[TBL] [Abstract][Full Text] [Related]
8. Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines.
Whitt MA
J Virol Methods; 2010 Nov; 169(2):365-74. PubMed ID: 20709108
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
10. Replicating-Competent VSV-Vectored Pseudotyped Viruses.
Yuan F; Zheng A
Adv Exp Med Biol; 2023; 1407():329-348. PubMed ID: 36920706
[TBL] [Abstract][Full Text] [Related]
11. Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay.
Kinoshita H; Yamada S; Ogawa T; Nguyen PHA; Harada S; Kawahara M; Ishijima K; Maeda K; Ebihara H; Fukushi S
mBio; 2024 Jun; ():e0109224. PubMed ID: 38847539
[TBL] [Abstract][Full Text] [Related]
12. Leucine-rich repeat-containing G protein-coupled receptor 4 facilitates vesicular stomatitis virus infection by binding vesicular stomatitis virus glycoprotein.
Zhang N; Huang H; Tan B; Wei Y; Xiong Q; Yan Y; Hou L; Wu N; Siwko S; Cimarelli A; Xu J; Han H; Qian M; Liu M; Du B
J Biol Chem; 2017 Oct; 292(40):16527-16538. PubMed ID: 28842478
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1.
Rose NF; Roberts A; Buonocore L; Rose JK
J Virol; 2000 Dec; 74(23):10903-10. PubMed ID: 11069984
[TBL] [Abstract][Full Text] [Related]
14. Niosomal virosome derived by vesicular stomatitis virus glycoprotein as a new gene carrier.
Asadikaram G; Poustforoosh A; Pardakhty A; Torkzadeh-Mahani M; Nematollahi MH
Biochem Biophys Res Commun; 2021 Jan; 534():980-987. PubMed ID: 33131770
[TBL] [Abstract][Full Text] [Related]
15. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
Mire CE; Miller AD; Carville A; Westmoreland SV; Geisbert JB; Mansfield KG; Feldmann H; Hensley LE; Geisbert TW
PLoS Negl Trop Dis; 2012; 6(3):e1567. PubMed ID: 22448291
[TBL] [Abstract][Full Text] [Related]
16. Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virus.
Ayala-Breton C; Russell LO; Russell SJ; Peng KW
J Virol; 2014 Aug; 88(15):8332-9. PubMed ID: 24829351
[TBL] [Abstract][Full Text] [Related]
17. Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum.
Pipperger L; Koske I; Wild N; Müllauer B; Krenn D; Stoiber H; Wollmann G; Kimpel J; von Laer D; Bánki Z
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243134
[TBL] [Abstract][Full Text] [Related]
18. Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.
van den Pol AN; Mao G; Chattopadhyay A; Rose JK; Davis JN
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077641
[TBL] [Abstract][Full Text] [Related]
19. Pseudotyping of vesicular stomatitis virus with the envelope glycoproteins of highly pathogenic avian influenza viruses.
Zimmer G; Locher S; Berger Rentsch M; Halbherr SJ
J Gen Virol; 2014 Aug; 95(Pt 8):1634-1639. PubMed ID: 24814925
[TBL] [Abstract][Full Text] [Related]
20. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
